A detailed history of Squarepoint Ops LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 16,246 shares of PGEN stock, worth $12,184. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,246
Holding current value
$12,184
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.91 - $1.88 $14,783 - $30,542
16,246 New
16,246 $15,000
Q1 2023

May 15, 2023

BUY
$0.88 - $2.19 $140,228 - $348,978
159,351 Added 888.69%
177,282 $187,000
Q4 2022

Feb 14, 2023

SELL
$1.27 - $2.26 $33,361 - $59,367
-26,269 Reduced 59.43%
17,931 $27,000
Q3 2022

Nov 14, 2022

SELL
$1.41 - $2.79 $48,006 - $94,991
-34,047 Reduced 43.51%
44,200 $94,000
Q2 2022

Aug 15, 2022

SELL
$1.15 - $2.53 $13,996 - $30,792
-12,171 Reduced 13.46%
78,247 $105,000
Q1 2022

May 16, 2022

SELL
$1.91 - $3.98 $16,970 - $35,362
-8,885 Reduced 8.95%
90,418 $191,000
Q4 2021

Feb 14, 2022

BUY
$3.53 - $5.5 $168,504 - $262,542
47,735 Added 92.57%
99,303 $368,000
Q3 2021

Nov 15, 2021

SELL
$4.99 - $6.55 $544,428 - $714,631
-109,104 Reduced 67.9%
51,568 $257,000
Q2 2021

Aug 16, 2021

BUY
$6.24 - $8.22 $678,537 - $893,842
108,740 Added 209.39%
160,672 $1.05 Million
Q1 2021

May 17, 2021

BUY
$6.74 - $10.95 $350,021 - $568,655
51,932 New
51,932 $358,000
Q4 2020

Feb 16, 2021

SELL
$3.75 - $10.56 $133,811 - $376,812
-35,683 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$3.5 - $6.2 $183,893 - $325,754
-52,541 Reduced 59.55%
35,683 $125,000
Q2 2020

Aug 14, 2020

BUY
$2.16 - $5.46 $190,563 - $481,703
88,224 New
88,224 $440,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $156M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.